Table 2.

Characteristics of men with localized prostate cancer in high-and low-use PADT health service areas

	Moderately-differentiated		Poorly-differentiated		All localized cancers
	High N=4,278	Low N=5,898	High N=1,433	Low N=1,478	High N=6,302	Low N=6,673
PADT within 180 days	2,058 (48.1%)	1,502 (25.5%)	1,058 (73.8%)	757 (51.2%)	3,321 (52.5%)	2,041 (30.6%)
PADT within 18 months	2,067 (48.3%)	1,652 (28.0%)	1,081 (75.6%)	815 (55.1%)	3,396 (53.9%)	2,247 (33.7%)
Mean duration of PADT use (months; standard deviation)	21 (30)	16 (29)	34 (34)	26 (33)	24 (31)	19 (31)
Median age at diagnosis (years; interquartile range)	78 (73–82)	77 (72–81)	79 (75–83)	79 (74–83)	78 (74–82)	77 (73–81)
Median zip-level income (interquartile range)	$41,284 (33,816–56, 958)	$44,939 (34,490–56,912)	$42,545 (35,091–59,722)	$41,580 (31,166–52,645)	$42,408 (34,382–60,669)	$44,107 (33,176–56,041)
Mean Charlson score (standard deviation)	0.22 (0.63)	0.22 (0.64)	0.19 (0.58)	0.22 (0.64)	0.21 (0.61)	0.22 (0.64)
Clinical stage T1	2,619 (61.2%)	3,742 (63.5%)	698 (48.7%)	739 (50.0%)	3,651 (57.9%)	3,901 (58.5%)